KYMR
Price
$43.58
Change
+$0.45 (+1.04%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
2.84B
59 days until earnings call
NUVB
Price
$2.44
Change
+$0.10 (+4.27%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
833.64M
64 days until earnings call
Interact to see
Advertisement

KYMR vs NUVB

Header iconKYMR vs NUVB Comparison
Open Charts KYMR vs NUVBBanner chart's image
Kymera Therapeutics
Price$43.58
Change+$0.45 (+1.04%)
Volume$45.03K
Capitalization2.84B
Nuvation Bio
Price$2.44
Change+$0.10 (+4.27%)
Volume$35.24K
Capitalization833.64M
KYMR vs NUVB Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. NUVB commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (KYMR: $43.13 vs. NUVB: $2.34)
Brand notoriety: KYMR and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 716% vs. NUVB: 192%
Market capitalization -- KYMR: $2.84B vs. NUVB: $796.22M
KYMR [@Biotechnology] is valued at $2.84B. NUVB’s [@Biotechnology] market capitalization is $796.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 7 TA indicator(s) are bullish while NUVB’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 7 bullish, 3 bearish.
  • NUVB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than NUVB.

Price Growth

KYMR (@Biotechnology) experienced а +46.25% price change this week, while NUVB (@Biotechnology) price change was +1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.47%, and the average quarterly price growth was +1.42%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

NUVB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.84B) has a higher market cap than NUVB($834M). KYMR YTD gains are higher at: 7.209 vs. NUVB (-12.030). KYMR has higher annual earnings (EBITDA): -232.67M vs. NUVB (-605.05M). KYMR (463M) and NUVB (462M) have equal amount of cash in the bank . NUVB has less debt than KYMR: NUVB (11.4M) vs KYMR (86.3M). KYMR has higher revenues than NUVB: KYMR (58.9M) vs NUVB (11M).
KYMRNUVBKYMR / NUVB
Capitalization2.84B834M340%
EBITDA-232.67M-605.05M38%
Gain YTD7.209-12.030-60%
P/E RatioN/AN/A-
Revenue58.9M11M535%
Total Cash463M462M100%
Total Debt86.3M11.4M757%
TECHNICAL ANALYSIS
Technical Analysis
KYMRNUVB
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCLCX17.99N/A
N/A
PACE Large Co Growth Equity P
PBLAX46.06N/A
N/A
Principal Blue Chip A
NWHYX14.35N/A
N/A
Nationwide Geneva Mid Cap Gr Instl Svc
AVUGX7.88N/A
N/A
American Century Value R5
PMPIX78.64N/A
N/A
ProFunds Precious Metals UltraSector Inv

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+45.51%
CCCC - KYMR
63%
Loosely correlated
+6.40%
NRIX - KYMR
61%
Loosely correlated
+14.21%
VERA - KYMR
58%
Loosely correlated
+67.49%
IMNM - KYMR
56%
Loosely correlated
+3.42%
ERAS - KYMR
54%
Loosely correlated
+1.79%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+10.38%
BEAM - NUVB
47%
Loosely correlated
+2.27%
ATXS - NUVB
46%
Loosely correlated
+0.42%
CLDX - NUVB
46%
Loosely correlated
+0.96%
EYPT - NUVB
45%
Loosely correlated
+2.49%
KYMR - NUVB
45%
Loosely correlated
+45.51%
More